Current Report · Items 5.02 · 8-K
SkinHealth Systems Inc.
SKINNASDAQEQUITYCurrent
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Effective September 3, 2026, the Board of Directors of SkinHealth Systems Inc. (the “Company”) promoted its Chief Financial Officer, Michael Monahan, to Chief Financial and Operating Officer (the “Promotion”). In connection with Mr.…
Filed Sep 10, 2026Accepted Sep 10, 2026, 4:05 PM EDTCIK 1818093Accession 0001628280-26-061326
Company context
SkinHealth Systems (NASDAQ: SKIN) is a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions designed to help consumers achieve superior skin health and support the success of providers. Anchored by Hydrafacial™, a leading and widely requested professional skincare treatment, and supported by complementary offerings including SkinStylus™ microneedling and HydraScalp™ with Keravive™, SkinHealth Systems combines advanced device technology, proprietary consumables, and clinical validation to deliver trusted treatment experiences through an omnichannel network of providers worldwide. Learn more at skinhealthsystems.com or follow us on LinkedIn. Local providers can be found at hydrafacial.com/find-a-hydrafacialist.
Current securities
Historical securities (4)
Disclosure sections
Items 5.02Select an item to read the extracted section. The as-filed document remains the primary evidence.
Item 5.02Item 5.02 - Departure/Election of Directors
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Effective September 3, 2026, the Board of Directors of SkinHealth Systems Inc. (the “Company”) promoted its Chief Financial Officer, Michael Monahan, to Chief Financial and Operating Officer (the “Promotion”). In connection with Mr. Monahan’s Promotion, he now oversees all of the Company’s financial operations and the Company’s supply chain, manufacturing, logistics, and customer experience. Effective September 15, 2026, Mr. Monahan's base salary will increase from $515,000 to $555,000 as a result of the Promotion.
Biographical information for Mr. Monahan is contained in the Company’s definitive proxy statement, filed with the U.S. Securities and Exchange Commission on April 24, 2026. There are no arrangements or understandings between Mr. Monahan and any other persons pursuant to which he was appointed to the position of Chief Financial and Operating Officer, there are no family relationships between Mr. Monahan and any of the Company’s directors or other executive officers, and there are no transactions between Mr. Monahan and the Company that would be required to be disclosed pursuant to Item 404(a) of Regulation S-K.